Factors related to the recurrent hyperfunction of autografts after total parathyroidectomy in patients with severe secondary hyperparathyroidism.
Total parathyroidectomy with autotransplantation has been widely accepted as the appropriate treatment for patients with hyperparathyroidism due to chronic renal failure on long term hemodialysis. However, recurrence has been an enigma and therefore, the factors involved in the recurrence of hyperparathyroidism were studied in 128 patients followed for more than 2 years after surgical treatment. The preoperative serum parathyroid hormone (PTH) concentrations correlated with the total weights of the parathyroid glands. When the original autotransplanted glands were divided into two groups, being diffuse and nodular, the rate of recurrent hyperparathyroidism due to graft hyperfunction was significantly higher in the patients who received nodular glands (24%) than in those who received diffuse glands (8.4%) (P < 0.05). To investigate whether PTH synthetic activity is different in diffuse and nodular glands, the amount of PTH mRNA was studied by in situ hybridization. There was no significant difference in the amount of PTH mRNA in the cells from either diffuse or nodular glands. These data suggest that the recurrence of hyperparathyroidism is not due to enhanced PTH synthetic activity of autotransplant grafts but to the abnormal growth rate of the transplanted gland.
Tanaka
Y
Y
Second Department of Surgery, Nagoya University School of Medicine, Japan.
Seo
H
H
Tominaga
Y
Y
Funahashi
H
H
Matsui
N
N
Takagi
H
H
D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000473:pathology / Q000503:physiopathology* / Q000601:surgery*; D017403:In Situ Hybridization; D008297:Male; D008875:Middle Aged; D009929:Organ Size; D010280:Parathyroid Glands / Q000473:pathology / Q000503:physiopathology* / Q000637:transplantation*; D010281:Parathyroid Hormone / Q000097:blood / Q000235:genetics / Q000378:metabolism; D016105:Parathyroidectomy; D012333:RNA, Messenger / Q000097:blood; D012008:Recurrence; D012307:Risk Factors; D012720:Severity of Illness Index
D010281:Parathyroid Hormone; D012333:RNA, Messenger